Marotte H - Search Results

1

Association between the level of circulating bioactive tumor necrosis factor alpha and the tumor necrosis factor alpha gene polymorphism at -308 in patients with rheumatoid arthritis treated with a tumor necrosis factor alpha inhibitor.

Marotte H, Arnaud B, Diasparra J, Zrioual S, Miossec P. Marotte H, et al. Arthritis Rheum. 2008 May;58(5):1258-63. doi: 10.1002/art.23430. Arthritis Rheum. 2008. PMID: 18438841 Free article.

2

Lupus erythematosus with leflunomide: induction or reactivation?

Gensburger D, Kawashima M, Marotte H, Kanitakis J, Miossec P. Gensburger D, et al. Among authors: marotte h. Ann Rheum Dis. 2005 Jan;64(1):153-5. doi: 10.1136/ard.2003.019323. Ann Rheum Dis. 2005. PMID: 15608317 Free PMC article.

3

Circulating tumour necrosis factor-alpha bioactivity in rheumatoid arthritis patients treated with infliximab: link to clinical response.

Marotte H, Maslinski W, Miossec P. Marotte H, et al. Arthritis Res Ther. 2005;7(1):R149-55. doi: 10.1186/ar1465. Epub 2004 Dec 1. Arthritis Res Ther. 2005. PMID: 15642135 Free PMC article.

4

The shared epitope is a marker of severity associated with selection for, but not with response to, infliximab in a large rheumatoid arthritis population.

Marotte H, Pallot-Prades B, Grange L, Tebib J, Gaudin P, Alexandre C, Blond JL, Cazalis MA, Mougin B, Miossec P. Marotte H, et al. Ann Rheum Dis. 2006 Mar;65(3):342-7. doi: 10.1136/ard.2005.037150. Epub 2005 Aug 11. Ann Rheum Dis. 2006. PMID: 16096333 Free PMC article.

5

The association between periodontal disease and joint destruction in rheumatoid arthritis extends the link between the HLA-DR shared epitope and severity of bone destruction.

Marotte H, Farge P, Gaudin P, Alexandre C, Mougin B, Miossec P. Marotte H, et al. Ann Rheum Dis. 2006 Jul;65(7):905-9. doi: 10.1136/ard.2005.036913. Epub 2005 Nov 10. Ann Rheum Dis. 2006. PMID: 16284099 Free PMC article.

6

Etanercept treatment for three months is safe in patients with rheumatological manifestations associated with hepatitis C virus.

Marotte H, Fontanges E, Bailly F, Zoulim F, Trepo C, Miossec P. Marotte H, et al. Rheumatology (Oxford). 2007 Jan;46(1):97-9. doi: 10.1093/rheumatology/kel191. Epub 2006 May 23. Rheumatology (Oxford). 2007. PMID: 16720634 Clinical Trial.

7

Overexpression of synoviolin in peripheral blood and synoviocytes from rheumatoid arthritis patients and continued elevation in nonresponders to infliximab treatment.

Toh ML, Marotte H, Blond JL, Jhumka U, Eljaafari A, Mougin B, Miossec P. Toh ML, et al. Among authors: marotte h. Arthritis Rheum. 2006 Jul;54(7):2109-18. doi: 10.1002/art.21926. Arthritis Rheum. 2006. PMID: 16802346 Free article.

8

Extensive multiallelic analysis of the relationship between HLA-DRB1 and rheumatoid arthritis using a Bayesian partition model.

Marotte H, Tournoud M, Cazalis MA, Mougin B, Roy P, Miossec P. Marotte H, et al. Genes Immun. 2006 Sep;7(6):487-93. doi: 10.1038/sj.gene.6364319. Epub 2006 Jul 6. Genes Immun. 2006. PMID: 16826237

9

Rheumatoid arthritis and genetic markers in Syrian and French populations: different effect of the shared epitope.

Kazkaz L, Marotte H, Hamwi M, Angélique Cazalis M, Roy P, Mougin B, Miossec P. Kazkaz L, et al. Among authors: marotte h. Ann Rheum Dis. 2007 Feb;66(2):195-201. doi: 10.1136/ard.2004.033829. Epub 2006 Oct 26. Ann Rheum Dis. 2007. PMID: 17068065 Free PMC article.

10

A 1-year case-control study in patients with rheumatoid arthritis indicates prevention of loss of bone mineral density in both responders and nonresponders to infliximab.

Marotte H, Pallot-Prades B, Grange L, Gaudin P, Alexandre C, Miossec P. Marotte H, et al. Arthritis Res Ther. 2007;9(3):R61. doi: 10.1186/ar2219. Arthritis Res Ther. 2007. PMID: 17597527 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results